Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Growth Factor Antagonists
Witt, Daniel P.
Repligen Corporation, Waltham, MA, United States
Search 3 grants from Daniel Witt
Search grants from Repligen Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
(PQ3) Cellular and Molecular Mechanisms Driving Myeloid Compartment Variation in Human Triple Negative Breast Cancer
TGFb and Cardiac Neural Crest Cell Fate and Function
Effect of Westernization on Infant Feeding Patterns Among Negev Bedouins
Computer Simulation of Chemical Dynamics
MOTI: Mining Bibliographic Information on Emerging Technologies
Recently added grants:
Functional Microbiomics, Inflammation and Pathogenicity
COBRE-Administrative Core
Functional Microbiomics Core-Bodduluri
Molecular Structure Determination by Mass Spectrometry and Computational Modeling
Novel synthetic analogue of microbial metabolite, Urolithin A, mitigates inflammatory bowel diseases
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
7R43EY011333-02
Application #
2020035
Study Section
Special Emphasis Panel (ZRG1-VISA (02))
Project Start
1996-03-16
Project End
1997-02-06
Budget Start
1996-03-16
Budget End
1997-02-06
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Repligen Corporation
Department
Type
DUNS #
City
Waltham
State
MA
Country
United States
Zip Code
02453
Comments
Be the first to comment on Daniel Witt's grant